chrisvoncsefalvay/vaers-outcomes huggingface dataset:
patient received vaccine on a thursday. she stopped into the store on saturday reporting that the site of the injection had been red and had raised bumps around it. she was concerned about a possible allergic reaction to the vaccine. she said it was also extremely itchy. i looked at the area and it was localized to just the area of injection and she said at this time it did not appear to be spreading. i recommended otc treatment with an antihistamine and informed pt to contact us or her doctor if the reaction worsened or did not improve
Nausea and vomiting 10 minutes post vaccine. Patient was escorted to the restroom by pharmacy staff. No additional symptoms noted.  A coworker drove patient home.
Arm pain. Swelling of injection site. Headache. Body ache. Heartrate dropped to 56. Was placed on a heart monitor for almost a week, waiting results of tests. Cardiologist said no sports, no heavy exercise, etc. Heartrate abnormally low.  Constant headaches turned into migraines. Stomach upset 3 days. Body aches. Sleepy and tired throughout the day. Forgetful.
sore knee got worse; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (sore knee got worse) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ARTHRALGIA (sore knee got worse). At the time of the report, ARTHRALGIA (sore knee got worse) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication details was reported. No treatment medication details was reported.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 57-year-old female patient (not pregnant) received bnt162b2, bnt162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 17Sep2022 at 12:00 as dose 5 (booster), single (Batch/Lot number: unknown) at the age of 56 years, in left arm for covid-19 immunisation; covid-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown), as dose 3 (booster), single (Batch/Lot number: unknown) and as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "High blood pressure" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Sep2023, outcome "unknown" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (Sep2023) Positive. Therapeutic measures were taken as a result of drug ineffective, covid-19. Clinical course: The patient received the Paxlovid treatment from 21Sep2023 to 25Sep2023. Patient had no known allergies  The information on the batch/lot number for bnt162b2, bnt162b2 omi ba.4-5 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300315554 Same patient, different drug/AE.;
Patient reported that 2 days after receiving Td injection he lost consciousness in the doctor's office while getting his blood drawn for the glucose test. Muscle stiffness next day, slight fever, continued weakness and nausea. Patient and begun a fast the night of the immunization for a glucose test being administered days 2 and 3 post immunization. Follow up received on 11/15/05: Patient (who is also the reporter of the adverse event) was contacted for additional information. Patient said that thyroid abnormalities are new, patient's thyroid was checked by a different doctor a year and a half ago. Muscles weakness experienced after Td immunization is getting better. Patient received Td due to a fractured left toe. Patient said that he is feeling better. Follow up received 11/22/05: Patient was contacted to clarify the thyroid test results of October 21st that showed an elevated thyroid peroxidase TPO. Patient is undergoing evaluation for thyroid and glucose abnormalities that preceded Td immunization, and as per manufacturer medical assessment, the thyroid/glucose test results are therefore unrelated to Td.
Narrative:  Patient reported developing joint pain and cold symptoms ~6 days after receiving second COVID 19 vaccine
NAUSEA Narrative: PATIENT MISSED ONE DAY OF  WORK Other Relevant History
COVID-19; Got very sick; This spontaneous case was reported by a pharmacist and describes the occurrence of COVID-19 (COVID-19) and ILLNESS (Got very sick) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Lupus syndrome and Immunocompromised.   In May 2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (COVID-19) and ILLNESS (Got very sick). At the time of the report, COVID-19 (COVID-19) and ILLNESS (Got very sick) outcome was unknown.      mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  The patient was treated with high dose steroids.   Reporter did not allow further contact
Tingling and spasms in my back muscles across my shoulder blades; Tingling and spasms in my back muscles across my shoulder blades; Nerve pain; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (Tingling and spasms in my back muscles across my shoulder blades), MUSCLE SPASMS (Tingling and spasms in my back muscles across my shoulder blades) and NEURALGIA (Nerve pain) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PARAESTHESIA (Tingling and spasms in my back muscles across my shoulder blades), MUSCLE SPASMS (Tingling and spasms in my back muscles across my shoulder blades) and NEURALGIA (Nerve pain). At the time of the report, PARAESTHESIA (Tingling and spasms in my back muscles across my shoulder blades), MUSCLE SPASMS (Tingling and spasms in my back muscles across my shoulder blades) and NEURALGIA (Nerve pain) outcome was unknown.            No concomitant medications were reported. No treatment medications were reported.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  An 80-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 19Jan2021 as dose 1, single (Lot number: EL9261), in right arm, on 09Feb2021 as dose 2, single (Lot number: EM9809), in right arm, on 17Sep2021 as dose 3 (booster), single (Lot number: FF2589), in right arm and on 09Apr2022 as dose 4 (booster), single (Lot number: FK9893) at the age of 80 years, in right arm for covid-19 immunisation. The patient's relevant medical history included: "psoriasis" (unspecified if ongoing); "Vitiligo" (unspecified if ongoing); "Known allergies: adhesive tape" (unspecified if ongoing), notes: Known allergies: adhesive tape. The patient's concomitant medications were not reported. Past drug history included: Statins, reaction(s): "known allergies: Statins", notes: known allergies: Statins; Zetia, reaction(s): "known allergies: zetia", notes: known allergies: zetia. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (19Sep2022) Positive, notes: did a home test for COVID-19. It was positive; (unspecified date) Positive, notes: COVID 19 Treatment. Therapeutic measures were taken as a result of vaccination failure, covid-19.
breast cancer; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP), Program ID: (Unknown).  A female patient received BNT162b2 (BNT162B2), as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose: 1), for COVID-19 immunization; Bnt162b2 (Dose: 2), for COVID-19 immunization. The following information was reported: BREAST CANCER (medically significant), outcome "unknown". The patient underwent the following laboratory tests and procedures: Investigation: lft breast cancer.  Clinical information: This case was for reporters 1st cousin. The reporter was trying to reach out to others or to medical world about Covid vaccine causing breast cancer. We do not have a family history. No genetics per either of our tests. Both myself and my 1st cousin were diagnosed this past year with the exact same type left breast cancer, same side, (we are different ages), same arm (vaccines all given in left arm). Both within 8-10 months of getting Pfizer 2 shots and 1 booster. The reporter even had pet scan month before my first shot due to funny blood work, negative.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
This is a spontaneous report from a contactable nurse. A 3-month-old male patient received a dose of PREVNAR 13 at 1013 hrs in the left thigh, a dose of Rotavirus vaccine, and a dose of PENTACEL all on an unknown date. Relevant medical history and concomitant medications were not reported. On an unknown date, the patient experienced crying. The patient recovered on an unknown date.
swelling area gland up to his neck, but has gone away on him; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (swelling area gland up to his neck, but has gone away on him) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced LYMPHADENOPATHY (swelling area gland up to his neck, but has gone away on him). At the time of the report, LYMPHADENOPATHY (swelling area gland up to his neck, but has gone away on him) had resolved.            No concomitant drug details were reported. No treatment details were reported.
Cardiac arrhythmia; hot flashes; Case reference number US-BN-2021-002196 is a spontaneous case report initially received from a consumer via GSK on 18-Aug-2021, and concerns 64-years-old female patient.  The patients' medical history and concomitant medication details were not provided.  On an unspecified date, the patient received RabaVert vaccine (Inactivated Rabies Virus Vaccine, Batch no. was not provided) at an unknown dose or route of administration, for an unknown indication.  On an unspecified date, an unknown amount of time after receiving the vaccine, the patient developed cardiac arrhythmia and hot flashes.  Outcome for the events was not provided.  The reporter did not provide seriousness or causality assessment for the events of cardiac arrhythmia and hot flashes.  Additional information received from GSK on 18-Aug-2021 included confirmation for the country of occurrence.  No further information was provided.; Reporter's Comments: Arrhythmia and hot flush are not listed for RabAvert per PI and PI. Reportedly, the patient experienced mentioned events after vaccination with suspect product, but chronology needs more clarification. Advanced age of patient (64-years-old) may have contributed to the development of the events. No information regarding patient's medical history and co-suspect and concomitant medication were provided. Based on available information causality between suspect product and event hot flush is assessed as possible and for event arrythmia as not related. The case is considered as non-serious.; Sender's Comments: Arrhythmia and hot flush are not listed for RabAvert per PI and PI. Reportedly, the patient experienced mentioned events after vaccination with suspect product, but chronology needs more clarification. Advanced age of patient (64-years-old) may have contributed to the development of the events. No information regarding patient's medical history and co-suspect and concomitant medication were provided. Based on available information causality between suspect product and event hot flush is assessed as possible and for event arrythmia as not related. The case is considered as non-serious.
localized then regional swelling, pain w/in 24hr;fever @ 24hr later;rash ant chest lt shoulder 24hr later;arthralgias lt shoulder, neck elbow;
Severe pain surrounding vaccine site, continuing at 1 month subsequent to vaccination and causing loss of range of motion of arm and shoulder in which vaccine was given.
Pt was positive for COVID in December 2021 as well.  Pt was found to be COVID positive again and admitted for acute on chronic hypoxic respiratory failure, sepsis due to community acquired pneumonia, and severe protein malnutrition due to cancer induced cachexia.
a weird sensation ran through my body, from my head to feet; I got lightheaded and weak; I had trouble texting like my fingers didn't have the strength.; warm; agitated; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 42 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 25Mar2021 14:15 (Lot number: ER8732) at the age of 42 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: VITAMIN D [COLECALCIFEROL]. Past drug history included: Vicodin, reaction(s): "Allergies: vicodin", notes: Known allergies Vicoden. The following information was reported: FEELING ABNORMAL (non-serious) with onset 25Mar2021 14:30, outcome "not recovered", described as "a weird sensation ran through my body, from my head to feet"; DIZZINESS (non-serious) with onset 25Mar2021 14:30, outcome "not recovered", described as "I got lightheaded and weak"; ASTHENIA (non-serious) with onset 25Mar2021 14:30, outcome "not recovered", described as "I had trouble texting like my fingers didn't have the strength."; FEELING HOT (non-serious) with onset 25Mar2021 14:30, outcome "not recovered", described as "warm"; AGITATION (non-serious) with onset 25Mar2021 02:30, outcome "not recovered", described as "agitated". The events "a weird sensation ran through my body, from my head to feet", "i got lightheaded and weak", "i had trouble texting like my fingers didn't have the strength.", "warm" and "agitated" were evaluated at the physician office visit and emergency room visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of feeling abnormal, dizziness, asthenia, feeling hot, agitation.  Additional Information: Patient went to a nurse who checked her pulse etc. Her heart rate was normal, but patient got pretty warm and agitated. It passed after about 50 minutes, though patient had to call someone to come drive her home. It was reported that a couple of days before she felt normal. Patient did not took any other vaccination within four weeks. Patient was not tested positive for Covid-19 prior as well as post vaccination.  No follow-up attempts are possible. No further information is expected.
Moderate soreness at injection site; chills; body aches; fatigue; dry mouth.
On 1/11/03, mom reports a thick mucous in mouth and nose and a temperature of 103F. While not usual side effect, mom, who is an RN, is adamant that the pt had not been exposed to any illness. Mom was advised to take pt to a medical clinic. On 1/22/03, mom "did not take her to clinic and is feeling fine now".
ringing in his ears; Arm left arm is sore. injection site; This is a spontaneous report received from a contactable consumer (patient) via medical information team. A 35-year-old male patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection), via an unspecified route of administration on an unknown date in Apr2021 as a single dose on for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. The patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot# EW0158, Expiration date: 31Jul2021) on 08Apr2021 as a single dose for COVID-19 immunization. On an unknown date at 2:45pm the patient got his 2nd shot of Pfizer, 6 am woke up with ringing in his ears, and his arm left arm is sore. injection site. The outcome of the events was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
- Large red circle patch around the injection site  - Bright red, somewhat swollen  - Itchy - Looks a bit like hives and feels like hives  - Started about one week after my shot. Did not have any abnormal coloring on my arm for week after shot.  - Turned red and itchy during the evening. Persisted throughout the next day and is still somewhat uncomfortable at the time of this submission  - Felt tired today  - Cold wash cloth on it felt soothing. Took antihistamine and that helped with the itchiness.
Nurse's Notes: Patient, Female, came in for covid-19 vaccine and flu vaccine. Patient came in conscious, coherent, alert. Covid vaccine was administered. Few minutes later, she verbalized, "I feel faint," she then fainted and almost hit her head on the floor, her head was supported with my hands. Called help from the pharmacist. Water was given and vital signs were taken. Her vitals were normal. Patient explained she had history of fainting and said it's probably because of or due to anxiety. Patient seemed relaxed. Hydration was fluids was advised. Vital signs taken again and were normal.
Fever 101 F degrees. Big red rash on upper right arm and swollen. Patient has been taking aspirin 325 mg every 4 hrs. It seemed to help with fever and redness and swollen last 8-9 days.
Information has been received from a lawyer regarding a case in litigation concerning a female patient (age unknown). The patient's medical history, concurrent conditions and concomitant medication use were not provided. During 2014, the patient was vaccinated with ZOSTAVAX, (lot# and route unknown) as recommended for routine adult health maintenance and for the prevention of shingles. The vaccine did not prevent shingles as intended, and the patient subsequently contracted a persistent strain of herpes zoster. On or about 15-NOV-2016, the patient was treated by a physician for a persistent vesicular rash, which was diagnosed as post-herpetic neuralgia, a chronic condition of pain and nerve damage secondary to herpes zoster infections. The patient has been prescribed gabapentin, oxycodone and acyclovir for management of her painful symptoms and chronic pain. As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
detached retina; This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a male patient (pt) of unknown age. No information regarding the pt's pertinent medical history, drug reactions or allergies, and concomitant medications was provided. On 08-SEP-2017, the pt was inoculated with zoster vaccine live (ZOSTAVAX) (dose, dose number, route of administration, anatomical site of vaccination, lot number and expiration date were not provided), for routine health maintenance and for the vaccine intended purpose: prevention of shingles (herpes zoster). On an unknown date, shortly after receiving the zoster vaccine live (ZOSTAVAX) vaccine, the pt suffered from a detached retina. As a direct and proximate result of the zoster vaccine live (ZOSTAVAX) vaccine, the pt 's symptoms had resulted in physical limitations not present prior to using the zoster vaccine live (ZOSTAVAX). The pt also experienced mental and emotional distress due to physical limitations and seriousness of his condition. As a result of the manufacture, marketing, advertising, promotion, distribution and/or sale of the zoster vaccine live (ZOSTAVAX), the pt sustained severe and permanent personal injuries. Furthr, as a tragic consequence of thezoster vaccine live (ZOSTAVAX), the pt suffered serious, progressive, permanent, and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. As a direct and proximate result of the zoster vaccine live (ZOSTAVAX), the pt had suffered and incurred damages, including medical expenses; the loss of accumulations; and other economic and non-economic damages. The outcome of the event was considered as not recovered. The reporter assessed that the event was related to the zoster vaccine live (ZOSTAVAX).  The reporter considered the event of detached retina to be disabling. Upon internal review, the event of detached retina was considered to be medically significant.
COVID positive 9-23-2021.  9-30-2021 20:29-aide went to get off toilet. resident stated she didn't feel good and went to go forward. aide lowered to the ground. resident pale, diaphoretic, resident had on non skid socks. resident had extra large bowel movement at time of episode. resident stated she got light headed and passed out.VS, full assessment, put into bed, notified MD, called family, notified supervisor, UM, intervention: all transfers sit to stand with two assist and PT to evaluate 10-01-2021 08:16am- Resident noted with c/o dizziness unable to stand and c/o heart thumping. VS 120/71, 97.9 115-159, 18 97%ra diaphoretic. Called placed to 911 resident sent out to hospital, called report to ED charge nurse POA is aware and will meet resident at hospital. Resident was A&O at time of transport.
Chronic acute systemic pain now at much higher pain levels. Tendinitis in right arm was at 3, now at 7. Back and neck was at 6, now at 9. Hips and knees were at 5 now at 7.5.
I have been on birth control for quite some time and I have a monthly period. I start taking my sugar pills on Monday and my period starts on Thursday (this happens consistently). After the covid vaccine, my period started about a week early while I was still taking the birth control pills and it lasted a week (usually is only 3 days).
Patient given adult dose of Pfizer. Patient experienced feeling soreness all over the day after getting the vaccination and now issues after that.